Literature DB >> 2003279

Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke.

B M Coull1, N Beamer, P de Garmo, G Sexton, F Nordt, R Knox, G V Seaman.   

Abstract

The origin and significance of blood hyperviscosity in subjects with acute stroke has been controversial. It has been argued that viscous abnormalities simply reflect either elevated hematocrit or an acute-phase response to the stroke itself. To address these issues, we measured the factors that determine blood viscosity in a cross-sectional study of 430 subjects, including 135 with acute stroke, 89 with acute transient ischemic attacks of the brain, 115 with recognized risk factors for stroke, and 91 healthy controls. The at-risk group was balanced with the acute stroke group for types of risk factors and medication usage, and all four groups were balanced for age. The viscosity of whole blood at low rates of shear and the plasma viscosity were significantly elevated in both groups with cerebrovascular symptoms and in the at-risk group compared with the healthy controls. The severity of hyperviscosity was stroke group greater than transient ischemic attack group greater than at-risk group greater than healthy controls. Increased viscosity of whole blood was associated with an elevated plasma fibrinogen concentration and with a decreased albumin/globulin ratio. This study provides evidence that blood hyperviscosity is present not only in subjects with acute brain infarction, but also in those with risk factors for stroke, and that these abnormalities are, to a considerable degree, chronic.

Entities:  

Mesh:

Year:  1991        PMID: 2003279     DOI: 10.1161/01.str.22.2.162

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain.

Authors:  Sahar A Fathallah-Shaykh; Ellen R Brooks; Craig B Langman; Kenneth R Kensey
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

2.  Fibrinogen.

Authors:  E Ernst
Journal:  BMJ       Date:  1991-09-14

3.  Improved model of fluorescence recovery expands the application of multiphoton fluorescence recovery after photobleaching in vivo.

Authors:  Kelley D Sullivan; William H Sipprell; Edward B Brown; Edward B Brown
Journal:  Biophys J       Date:  2009-06-17       Impact factor: 4.033

4.  Nonvalvular atrial fibrillation: evidence for a prothrombotic state.

Authors:  S R Kahn; S Solymoss; K M Flegel
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

5.  Validated formulae for estimation of whole blood viscosity underestimate the influence of erythrocyte aggregation and deformability.

Authors:  Joseph Weidman; Gregory Sloop; John A St Cyr
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-04-07

Review 6.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

7.  In vivo quantification of lymph viscosity and pressure in lymphatic vessels and draining lymph nodes of arthritic joints in mice.

Authors:  Echoe M Bouta; Ronald W Wood; Edward B Brown; Homaira Rahimi; Christopher T Ritchlin; Edward M Schwarz
Journal:  J Physiol       Date:  2014-01-13       Impact factor: 5.182

8.  Hemorheology and microvascular disorders.

Authors:  Young-Il Cho; Daniel J Cho
Journal:  Korean Circ J       Date:  2011-06-30       Impact factor: 3.243

9.  Microembolus detection by transcranial Doppler sonography: review of the literature.

Authors:  Vlasta Vuković-Cvetković
Journal:  Stroke Res Treat       Date:  2011-11-30

10.  Cerebral infarction in IgG multiple myeloma with hyperviscosity.

Authors:  Man-Seok Park; Byeong-Chae Kim; In-Kyu Kim; Seung-Han Lee; Sung-Min Choi; Myeong-Kyu Kim; Shin-Seok Lee; Ki-Hyun Cho
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.